Hedge Fund - Baker Bros. Advisors
Madrigal Pharmaceuticals Inc. ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $455,771,861 | 5.18% | 1,969,798 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $225,648,303 | 1.3% | 1,545,113 | $ |
| 3 | 2023 - Q2 (2023-06-30) | $356,921,103 | 2.06% | 1,545,113 | $ |
| 4 | 2023 - Q1 (2023-03-31) | $374,319,075 | 2.03% | 1,545,113 | $ |
| 5 | 2022 - Q4 (2022-12-31) | $448,469,048 | 2.69% | 1,545,113 | $ |
| 6 | 2022 - Q3 (2022-09-30) | $97,434,000 | 0.63% | 1,499,213 | $ |
| 7 | 2022 - Q2 (2022-06-30) | $107,314,000 | 0.6% | 1,499,213 | $ |
| 8 | 2022 - Q1 (2022-03-31) | $147,103,000 | 0.84% | 1,499,213 | $ |
| 9 | 2021 - Q4 (2021-12-31) | $127,043,000 | 0.61% | 1,499,213 | $ |
| 10 | 2021 - Q3 (2021-09-30) | $119,622,000 | 0.52% | 1,499,213 | $ |
| 11 | 2021 - Q2 (2021-06-30) | $146,038,000 | 0.64% | 1,499,213 | $ |
| 12 | 2021 - Q1 (2021-03-31) | $175,363,000 | 0.76% | 1,499,213 | $ |
| 13 | 2020 - Q4 (2020-12-31) | $166,668,000 | 0.62% | 1,499,213 | $ |
| 14 | 2020 - Q3 (2020-09-30) | $178,002,000 | 0.71% | 1,499,213 | $ |
| 15 | 2020 - Q2 (2020-06-30) | $169,786,000 | 0.74% | 1,499,212 | $ |
| 16 | 2020 - Q1 (2020-03-31) | $100,087,000 | 0.61% | 1,499,212 | $ |
| 17 | 2019 - Q4 (2019-12-31) | $106,533,000 | 0.56% | 1,169,278 | $ |
| 18 | 2019 - Q3 (2019-09-30) | $100,815,000 | 0.68% | 1,169,278 | $ |
| 19 | 2019 - Q2 (2019-06-30) | $122,552,000 | 0.83% | 1,169,278 | $ |
| 20 | 2019 - Q1 (2019-03-31) | $146,464,000 | 0.93% | 1,169,278 | $ |
| 21 | 2018 - Q4 (2018-12-31) | $131,801,000 | 1.07% | 1,169,278 | $ |
| 22 | 2018 - Q3 (2018-09-30) | $250,377,000 | 1.64% | 1,169,278 | $ |
| 23 | 2018 - Q2 (2018-06-30) | $327,035,000 | 2.45% | 1,169,278 | $ |
| 24 | 2018 - Q1 (2018-03-31) | $71,906,000 | 0.6% | 615,684 | $ |
| 25 | 2017 - Q4 (2017-12-31) | $56,514,000 | 0.48% | 615,684 | $ |
| 26 | 2017 - Q3 (2017-09-30) | $2,598,000 | 0.02% | 57,762 | $ |
| 27 | 2017 - Q2 (2017-06-30) | $939,000 | 0% | 57,762 | $ |
| 28 | 2017 - Q1 (2017-03-31) | $890,000 | 0% | 57,762 | $ |
| 29 | 2016 - Q4 (2016-12-31) | $861,000 | 0% | 57,762 | $ |
| 30 | 2016 - Q3 (2016-09-30) | $732,000 | 0% | 57,762 | $ |
The displayed share prices are average quarterly stock market prices.